| scholarly article | Q13442814 |
| case report | Q2782326 |
| P2093 | author name string | C Chizzolini | |
| S Vulliemoz | |||
| M Seeck | |||
| G Vanini | |||
| A Truffert | |||
| P2860 | cites work | Homozygosity for a missense mutation in the 67 kDa isoform of glutamate decarboxylase in a family with autosomal recessive spastic cerebral palsy: parallels with Stiff-Person Syndrome and other movement disorders | Q24802555 |
| GABA and glutamate in the human brain | Q28216691 | ||
| Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase | Q33744544 | ||
| Autoantibodies to glutamic acid decarboxylase in downbeat nystagmus | Q35474899 | ||
| Review of 23 patients affected by the stiff man syndrome: clinical subdivision into stiff trunk (man) syndrome, stiff limb syndrome, and progressive encephalomyelitis with rigidity | Q36318955 | ||
| Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome | Q41196484 | ||
| Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases | Q42206137 | ||
| Anti-GAD antibodies and periodic alternating nystagmus | Q46640935 | ||
| Serum antibodies in epilepsy and seizure-associated disorders | Q46848031 | ||
| Temporal-lobe epilepsy associated with glutamic-acid-decarboxylase autoantibodies. | Q47670840 | ||
| Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome | Q47671744 | ||
| Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients | Q49029367 | ||
| Glutamic acid decarboxylase autoantibodies in controlled and uncontrolled epilepsy: a pilot study. | Q54030379 | ||
| Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus. | Q55034045 | ||
| Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition | Q70844237 | ||
| Improvement of stiff-man syndrome with vigabatrin | Q73245635 | ||
| Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy | Q73986186 | ||
| Excellent response to steroid treatment in anti-GAD cerebellar ataxia | Q79078341 | ||
| Antigenic differences between neurological and diabetic patients with anti-glutamic acid decarboxylase antibodies | Q81603429 | ||
| The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies | Q81858038 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebellar ataxia | Q154709 |
| P304 | page(s) | 187-189 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies | |
| P478 | volume | 78 |
| Q38390857 | Acquired ataxias: the clinical spectrum, diagnosis and management |
| Q41087325 | Adenocarcinoma of Lung Presenting as Lambert-Eaton Myasthenic Syndrome |
| Q34589713 | Advances in the pathogenesis and treatment of patients with stiff person syndrome |
| Q86504078 | Anti-GAD Antibody, Seizures, Cerebellar Ataxias and Vitiligo: A Diagnostic Challenge |
| Q85965150 | Anti-GAD antibody ocular flutter: expanding the spectrum of autoimmune ocular motor disorders |
| Q41977560 | Anti-glutamic Acid decarboxylase antibody-associated ataxia as an extrahepatic autoimmune manifestation of hepatitis C infection: a case report |
| Q50056608 | Antiglutamic acid decarboxylase 65 (GAD65) antibody-associated epilepsy. |
| Q27693329 | Ataxia |
| Q28264405 | Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes |
| Q36826497 | Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy |
| Q39423412 | Cerebellar disease associated with anti-glutamic acid decarboxylase antibodies: review |
| Q37807591 | Clinical presentation of immune-mediated cerebellar ataxia |
| Q46821650 | Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus |
| Q48391296 | Epilepsia partialis continua in type 1 diabetes: evolution into epileptic encephalopathy with continuous spike-waves during slow sleep |
| Q26777428 | Guidelines for treatment of immune-mediated cerebellar ataxias |
| Q50765308 | High frequency of intrathecal immunoglobulin synthesis in epilepsy so far classified cryptogenic. |
| Q37795443 | Immunological aspects of epilepsy. |
| Q35651883 | Limbic encephalitis with antibodies to glutamic acid decarboxylase presenting with brainstem symptoms |
| Q48100215 | Low-Titre GAD Antibody-Associated Late-Onset Cerebellar Ataxia with a Significant Clinical Response to Intravenous Immunoglobulin Treatment. |
| Q30540585 | Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats |
| Q92242610 | Neurological Disorders Associated with Glutamic Acid Decarboxylase Antibodies |
| Q48945760 | New-onset focal epilepsy with palatal tremor and glutamic acid decarboxylase antibodies responding to intravenous immunoglobulin |
| Q48726404 | Prevalence and immunological spectrum of temporal lobe epilepsy with glutamic acid decarboxylase antibodies. |
| Q43244298 | Refractory generalized seizures and cerebellar ataxia associated with anti-GAD antibodies responsive to immunosuppressive treatment |
| Q48751128 | Stiff person syndrome: advances in pathogenesis and therapeutic interventions |
Search more.